APA (7th ed.) Citation

Y, X., F, Z., C, D., J, B., Y, L., J, Y., . . . M, L. (2026). Non-covalent proteasome inhibitor PI1840 suppresses osteoclastogenesis and prevents LPS-induced osteolysis in mice. Inflammopharmacology, 34(4), 2579. https://doi.org/10.1007/s10787-026-02175-9

Chicago Style (17th ed.) Citation

Y, Xia, et al. "Non-covalent Proteasome Inhibitor PI1840 Suppresses Osteoclastogenesis and Prevents LPS-induced Osteolysis in Mice." Inflammopharmacology 34, no. 4 (2026): 2579. https://doi.org/10.1007/s10787-026-02175-9.

MLA (9th ed.) Citation

Y, Xia, et al. "Non-covalent Proteasome Inhibitor PI1840 Suppresses Osteoclastogenesis and Prevents LPS-induced Osteolysis in Mice." Inflammopharmacology, vol. 34, no. 4, 2026, p. 2579, https://doi.org/10.1007/s10787-026-02175-9.